studied extensively; however, our understanding of P450 suppression is less clear (Riddick et al., 2004) . Data from our laboratory (Jones and Riddick, 1996) , in agreement with earlier studies [reviewed in (Riddick et al., 2003) ] as well as recent studies (Shaban et al., 2005; Caron et al., 2006) , report that exposure of male rats to aromatic hydrocarbons results in the suppression of hepatic CYP2C11 catalytic activity, protein and mRNA levels via an unknown pre-translational mechanism.
CYP2C11 is the major male-specific constitutive P450 present in the rat liver. The malecharacteristic pulsatile pattern of growth hormone (GH) secretion is the main physiological signal regulating the expression of this gene. This regulation occurs at the transcriptional level by a combination of direct and indirect actions involving the Janus kinase 2 (JAK2)-signal transducer and activator of transcription 5b (STAT5b) pathway as well as hepatic nuclear factors (HNFs) (Holloway et al., 2006; Waxman and O'Connor, 2006) .
In vivo suppression of CYP2C11 by MC is at least partially regulated at the level of gene transcription as shown by nuclear run-on analysis (Lee and Riddick, 2000) . We showed previously that MC and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) do not down-regulate expression of CYP2C11-luciferase reporter constructs containing up to 10.1-kb of the CYP2C11 5'-flank in transient transfection assays in cell culture (Bhathena et al., 2002; Sawaya and 
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6 plasmid DNA expression in hepatocytes upon rapid injection of a large volume (equivalent to 8-12% of the rat's body weight) of DNA-containing solution into the tail vein (Maruyama et al., 2002) .
We hypothesize that the in vivo suppression of CYP2C11 by aromatic hydrocarbons is mediated by the gene's promoter and 5'-flank. To identify regulatory sequences involved in mediating transcriptional down-regulation of this gene, we have studied the MC-responsiveness of luciferase constructs under the control of various lengths of the CYP2C11 5'-flank in living rats using the hydrodynamics-based approach.
This article has not been copyedited and formatted. The final version may differ from this version. 
Animals and Treatment. Male Fischer 344 rats (7-9 weeks of age; 150-200 g) were purchased from Charles River Canada (St.-Constant, Quebec, Canada). Rats were fed Harlan Teklad rodent laboratory chow and water ad libitum. All animal experimentation was approved by the University of Toronto Animal Care Committee and rats were cared for in accordance with guidelines of the Canadian Council on Animal Care. Rats were housed two animals per cage, and exposed to a 12-h light cycle followed by a 12-h dark cycle. Animals were acclimatized to living conditions in the Division of Comparative Medicine at the University of Toronto for 7 days before experimental procedures were begun.
Prior to hydrodynamics-based injections, rats were anesthetized by isoflurane inhalation (5% isoflurane in oxygen for induction; 2% isoflurane in oxygen for maintenance). Rats received a single intraperitoneal (i.p.) injection of either MC (80 mg/kg; Aldrich Chemical Company, Milwaukee, WI; 98% purity) or an equivalent volume of vehicle (sterile Mazola corn oil). Rats were then injected via the tail vein with a firefly luciferase plasmid and the pRL-TK Renilla luciferase plasmid dissolved in sterile lactated Ringer's solution (130 mM Na, 4 mM K, 1.4 mM Ca, 109 mM Cl, 28 mM lactate; Baxter Co., Mississauga, Ontario, Canada) at a volume equivalent to 8% of the rat's body weight. Injection time never exceeded 10 s. The Renilla construct was used to normalize for DNA transfection efficiency into the liver. Tail vein injections were performed using a 22-guage, 1-inch long catheter connected to a 25 ml-capacity syringe. Each rat received 20 µg of firefly luciferase plasmid and 1.75 µg of Renilla plasmid DNA per ml of Ringer's solution injected, with the following exceptions. Rats euthanized at 24 and 72 h after injection with the (-5.6-2C11) plasmid and rats euthanized at 6 h after injection with the (-10.1-2C11) plasmid received 5 µg of firefly luciferase plasmid and 0.5 µg of Renilla plasmid DNA per ml of Ringer's solution. These plasmid amounts fall within optimal ranges This article has not been copyedited and formatted. The final version may differ from this version. (Liu et al., 1999; Maruyama et al., 2002) .
Rats were euthanized by decapitation at 24 h or 72 h following high-volume injections.
Rats receiving the (-10.1-2C11) plasmid were also studied at an earlier time-point of 6 h postinjection. The liver of each rat was perfused in situ with ice-cold 1.15% KCl. Livers were excised and weighed. Small pieces of individual livers (~ 0.1 g) were frozen in liquid nitrogen and stored at -70°C until RNA isolation was performed. Fresh liver (1.5 g) isolated from the left-lobe of each rat was homogenized in 1 ml of 1X passive lysis buffer (Promega).
Homogenates were centrifuged at 4°C for 25 min at 15 000 x g. The supernatant was stored at -70°C until dual luciferase assays were performed. Thawed supernatant (20 µ l) was mixed with 100 µ l luciferase assay reagent II (Promega). Firefly luciferase activity was measured using a TD-20/20 luminometer (Turner Designs, Inc., Sunnyvale, CA). Stop and glow buffer (100 µ l)
was then added and Renilla luciferase activity was measured. The firefly luciferase activity was normalized to Renilla luciferase activity.
all RNA samples were treated with 20 U 
RESULTS
We have studied how MC affects luciferase plasmids driven by various lengths of the CYP2C11 5'-flank in living rats. Based on previous bioinformatic analyses (Sawaya and Riddick, 2008) , we have focused on the proximal 10.1-kb region of the 5'-flank. This region is particularly enriched for DRE-like motifs (also known as AHRE-I elements) and also contains one perfect match to the AHRE-II consensus sequence, a novel site first identified in the CYP1A2 gene that binds an unknown factor that recruits the AHR•ARNT complex as a coactivator (Boutros et al., 2004; Sogawa et al., 2004) . This region also contains putative sites for
TFs involved in GH regulation of this gene (STAT5, HNF-3) (Park and Waxman, 2001; Timsit and Riddick, 2002) and NF-κB response elements which can mediate suppression of this gene by inflammatory cytokines (Iber et al., 2000) . (Fig. 1B) . pGL3-Basic is a luciferase reporter plasmid devoid of an eukaryotic promoter, thus serving as a negative control for aromatic hydrocarbon responsiveness. MC induced pGL3-Basic luciferase activity slightly at both time-points studied, but this response was not statistically significant. At 24 h post-treatment, all CYP2C11
constructs were down-regulated by MC compared to vehicle-treated rats. The most pronounced down-regulation was observed with (-5.6-2C11), which was suppressed to 36% of vehicle levels.
(-2.4-2C11) showed the smallest magnitude of suppression 24 h post-treatment, being decreased to 63% of vehicle levels. At 72 h, luciferase activity of (-10.1-2C11) and (-5.6-2C11) plasmids was strikingly down-regulated in response to MC treatment by 69% and 76%, respectively.
Suppression of (-5.6-2C11) did not achieve statistical significance at 72 h since vehicle-treated rats displayed large variation in basal luciferase activity, whereas the variation at 24 h was minimal (Table 3) . MC up-regulated (-2.4-2C11) luciferase activity by 53% at 72 h; however, this was not statistically significant. Since all plasmids displayed a decline in luciferase activity by MC at 24 h, we examined an earlier time-point of 6 h post-injection in rats receiving the (-10.1-2C11) plasmid, to gain a clearer understanding of the time course involved in CYP2C11
reporter suppression. Regardless of chemical treatment, large variation in normalized luciferase activity was observed at this early time-point (Table 3 ). There was a 43% decline in luciferase activity 6 h following MC administration, an effect that was not statistically significant (Fig. 1B) .
This article has not been copyedited and formatted. The final version may differ from this version. For CYP2C11 constructs that were suppressed by MC at both 24 h and 72 h, basal luciferase activity in vehicle-treated rats was always higher at 72 h after injection (Table 3 ). The opposite trend was observed for pGudluc1.1 and pGL3-Basic luciferase activity, which displayed high levels of activity at 24 h, tapering off by 72 h post-treatment. All Renilla luciferase levels were relatively similar within a single plasmid group at the same time-point, indicating consistent transfection efficiencies between rats. Renilla luciferase values were higher when examined at 24 h post-treatment and were considerably lower by 72 h for all rats.
The effectiveness of the MC treatment was further confirmed by monitoring induction of endogenous CYP1A1 protein in rats receiving high-volume tail vein injections as a qualitative positive control response. MC markedly induced CYP1A1 protein ( Fig. 2A ) at all time-points regardless of plasmid administered, although the extent of induction varied between individual rats. The effects of MC administration on endogenous hepatic CYP2C11 expression in rats receiving hydrodynamics-based injections were examined at the protein level (Fig. 2B,C) .
Suppression of CYP2C11 protein levels by MC was detected at 24 h (62-77% of vehicle levels); however, statistical significance was achieved only in rats receiving pGudluc1.1, (-10.1-2C11) and (-2.4-2C11). Dramatic down-regulation of CYP2C11 protein was observed at 72 h in MCtreated rats receiving pGL3-Basic, pGudluc1.1 and (-5.6-2C11) with levels falling to 24-54% of vehicle levels. Rats receiving (-2.4-2C11) showed no overall changes in CYP2C11 protein levels between vehicle-and MC-treatment at 72 h. These rats displayed high levels of variation in CYP2C11 protein with standard deviations ranging from 45-54% of the mean. No differences in CYP2C11 protein levels were detected between MC-and vehicle-treated rats at 6 h.
As an additional qualitative positive control, MC markedly induced CYP1A1 mRNA (Fig. 3A,B ) at all time-points regardless of plasmid administered, although the extent of This article has not been copyedited and formatted. The final version may differ from this version. induction varied between individual rats. We used real-time quantitative RT-PCR to determine whether endogenous hepatic CYP2C11 mRNA expression was down-regulated by MC in rats receiving hydrodynamics-based injections (Fig. 3C) . At 24 h, modest trends for CYP2C11 mRNA suppression were observed in MC-treated rats receiving high-volume injections (67-76% of vehicle levels), but statistical significance was only achieved in rats receiving (-5.6-2C11).
Suppression of endogenous CYP2C11 mRNA levels was detected at 72 h in all rats (52-69% of vehicle control) except rats receiving pGL3-Basic. Statistical significance at 72 h was achieved in rats receiving pGudluc1.1 and (-10.1-2C11), since large variation in CYP2C11 mRNA expression was observed in vehicle-treated rats receiving (-5.6-2C11) and (-2.4-2C11) (data not shown). At 6 h post-treatment, no suppression of CYP2C11 mRNA levels following MC treatment was observed.
In general, CYP2C11 protein levels paralleled CYP2C11 mRNA levels (Fig. 4) . A significant positive correlation was observed between endogenous CYP2C11 mRNA and protein levels in rats receiving all plasmids by high-volume tail vein injection except for rats in the (-2.4-2C11) plasmid group. For CYP2C11 constructs strongly suppressed by MC [(-10.1-2C11) and (-5.6-2C11)], luciferase activity was positively correlated with endogenous CYP2C11 mRNA levels ( Fig. 5A,B) . Luciferase activity of (-2.4-2C11) was down-regulated at 24 h following MC treatment but showed a trend for an increase at 72 h, resulting in significant negative correlation between luciferase activity and CYP2C11 mRNA expression (Fig. 5C ). pGudluc1.1 luciferase activity displayed a slight trend for negative correlation with endogenous CYP2C11 mRNA levels; however, this was not statistically significant (Fig. 5D ). There was no significant relationship between pGL3-Basic luciferase activity and endogenous CYP2C11 mRNA (data not shown).
This article has not been copyedited and formatted. The final version may differ from this version. Endogenous CYP2C11 protein and mRNA levels are quite variable in both vehicle-and MC-treated rats receiving high-volume injections, a finding that coincides with variability in our qualitative assessment of CYP1A1 induction ( Fig. 2A, 3A ). This variability, together with the small numbers of animals used in this study, results in some data trends that do not achieve statistical significance. Overall there was a positive correlation between CYP2C11 mRNA and protein levels in individual rats that reached significance in all but one of the five plasmid treatment groups. This further supports a pre-translational mechanism for the down-regulation of CYP2C11 protein by MC. The half-life of CYP2C11 mRNA in primary rat hepatocytes has been reported to be 9.8 h (Iber et al., 2000) and 16 h (Bhathena et al., 2002) . Since MC is able to cause partial suppression of the rate of gene transcription within 6 h (Lee and Riddick, 2000) and blockage of transcription is not complete due to ongoing MC metabolism, we included timepoints that would give us a realistic window for detecting suppression of endogenous CYP2C11
and reporter plasmids: 24 h, 72 h, as well as 6 h in rats receiving (-10.1-2C11). A prior study in our laboratory found that maximal suppression of endogenous CYP2C11 protein and mRNA occurs between 72 h to 120 h following in vivo MC treatment (Jones and Riddick, 1996) . In the present study, there was an overall trend for down-regulation of endogenous CYP2C11
This article has not been copyedited and formatted. The final version may differ from this version. expression at 24 h and 72 h, but not at 6 h (Fig. 2C, 3C ).
Endogenous CYP2C11 levels in rats receiving high-volume injections were not uniform in their response to MC between the five plasmid groups. This may result if the high-volume injection itself elicits an inflammatory response in rats, stimulating the release of proinflammatory cytokines that are implicated in decreasing CYP2C11 transcription (Iber et al., 2000) . Although we used procedures to generate endotoxin-free plasmids, injection of plasmids containing variable endotoxin concentrations may down-regulate endogenous CYP2C11 levels suppression of other genes following TCDD treatment [reviewed in (Riddick et al., 2003) ]. To verify the involvement of the AHR in suppression of our CYP2C11-luciferase constructs we attempted, but did not succeed, in antagonizing the receptor in vivo using the AHR antagonist/partial agonist α-naphthoflavone (data not shown).
The second mechanistic possibility involves interference by MC with hormonal signaling pathways involved in CYP2C11 expression. The mechanisms behind suppression of numerous P450s following aromatic hydrocarbon treatment are unknown (Kurose et al., 1998; Lee et al., 2006; Ovando et al., 2006; Ning et al., 2008) but several components of the GH receptor/JAK2/STAT5b pathway have been shown to be targets for disruption by MC in mice (Nukaya et al., 2004; Lee et al., 2006) . In hypophysectomized (hypx) male rats, MC interferes with the ability of exogenous GH to stimulate hepatic CYP2C11 expression (Timsit and Riddick, 2000) . Ethylbenzene, a simple aromatic hydrocarbon, can decrease CYP2C11 protein only in intact but not in hypx rats (Serron et al., 2001) . Such findings suggest that CYP2C11 downregulation by aromatic hydrocarbons may occur by a mechanism that disrupts the ability of GH to maintain constitutive CYP2C11 expression.
A third possible mechanism of MC-mediated CYP2C11 suppression involves inflammatory cytokines. Increased NF-кB binding activity and protein levels have been reported following exposure to the PAH benzo[a]pyrene (Weng et al., 2004) . Inflammatory cytokines activated by MC could act to suppress our constructs by directly binding to NF-кB responsive elements on the CYP2C11 5'-flank (Iber et al., 2000) or by interfering with GH signaling (Ahmed et al., 2007) .
Previous studies of our CYP2C11-luciferase constructs in HepG2 cells revealed paradoxical induction of the reporter gene that is AHR-dependent and DRE-mediated (Sawaya This article has not been copyedited and formatted. The final version may differ from this version. and Riddick, 2008) . Conversely, we found that these same reporter plasmids were suppressed by MC treatment when studied in the living rat, a response that is analogous to the behavior of the endogenous CYP2C11 gene. Similarly, Sasaki et al. (1999) found that studying GH regulation of rat CYP2C12 reporter constructs in living rats was more mechanistically accurate compared to when these constructs were studied in HepG2 cells. Reporter gene results obtained in cell lines may not reliably predict in vivo responses of the endogenous gene to xenobiotic treatment.
Studying mechanisms of CYP2C11 suppression has useful implications from both a clinical and molecular viewpoint. P450 suppression is of clinical significance as shown by altered drug toxicity in patients during inflammatory conditions (Morgan et al., 2008) . Although the sex difference of hepatic P450 expression is not as obvious in humans as in rats, it does exist and appears to be under hormonal control (Dhir et al., 2006) . Recently, human CYP2C8 was shown to be down-regulated in primary human hepatocytes treated with MC (Ning et al., 2008) .
Consequently, studies of molecular mechanisms involved in control of rat P450s have the potential to reveal fundamental mechanistic pathways that could be conserved in other mammals.
We plan to use CYP2C11 as a model system to understand how PAHs decrease the transcription of other hormonally-regulated genes.
This is the first demonstration of aromatic hydrocarbon-mediated suppression of a CYP2C11-luciferase construct in any biological system. Sequences responsible for CYP2C11
reporter suppression by MC exist in the proximal 2.4-kb of the 5'-flank and additional cis-acting elements located between -5.6-kb and -2.4-kb mediate persistent reporter suppression.
Additional deletion constructs and site-directed mutants introduced to living rats by the hydrodynamics approach will more precisely define the sequences mediating suppression, while in vivo chromatin immunoprecitation assays will allow us to study protein-DNA interactions in All data are expressed in arbitrary light units (normalized for Renilla activity) as mean ± S.D. of determinations from hepatic lysates prepared from three or four rats. Statistically significant effects of MC are summarized in Fig. 1 .
N.D., not determined
This article has not been copyedited and formatted. The final version may differ from this version.
